134 related articles for article (PubMed ID: 20199720)
1. [Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Zhang J; Wang KX; Wei Y; Xu MH; Su JM; Bao YG; Zhao SY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):96-8. PubMed ID: 20199720
[TBL] [Abstract][Full Text] [Related]
2. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
3. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children].
Boldyreva SR; Ermakov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):41-7. PubMed ID: 20517209
[TBL] [Abstract][Full Text] [Related]
5. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic frontal lobe epilepsy in children].
Boldyreva SR; Ermakov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):58-65. PubMed ID: 20559276
[TBL] [Abstract][Full Text] [Related]
6. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bone mineral density in children receiving antiepileptic drugs.
Akin R; Okutan V; Sarici U; Altunbas A; Gökçay E
Pediatr Neurol; 1998 Aug; 19(2):129-31. PubMed ID: 9744632
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
9. Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes.
Voudris KA; Attilakos A; Katsarou E; Garoufi A; Dimou S; Skardoutsou A; Mastroyianni S
J Child Neurol; 2005 Jun; 20(6):513-6. PubMed ID: 15996401
[TBL] [Abstract][Full Text] [Related]
10. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy.
Kang HC; Eun BL; Wu Lee C; Ku Moon H; Kim JS; Wook Kim D; Soo Lee J; Young Chae K; Ho Cha B; Sook Suh E; Chae Park J; Lim K; Hye Ha E; Ho Song D; Dong Kim H;
Epilepsia; 2007 Sep; 48(9):1716-1723. PubMed ID: 17561952
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up.
Kim JM; Kwon S; Seo HE; Choe BH; Cho MH; Park SP
J Korean Med Sci; 2009 Dec; 24(6):1078-82. PubMed ID: 19949663
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic Drugs and Bone Health in Thai Children with Epilepsy.
Paticheep S; Chotipanich C; Khusiwilai K; Wichaporn A; Khongsaengdao S
J Med Assoc Thai; 2015 Jun; 98(6):535-41. PubMed ID: 26219156
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
17. Effect of Long-term Carbamazepine Therapy on Bone Health.
Suljic EM; Mehicevic A; Mahmutbegovic N
Med Arch; 2018 Oct; 72(4):262-266. PubMed ID: 30514991
[TBL] [Abstract][Full Text] [Related]
18. The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism.
Simko J; Fekete S; Gradosova I; Malakova J; Zivna H; Valis M; Palicka V; Zivny P
J Neurol Sci; 2014 May; 340(1-2):80-5. PubMed ID: 24629477
[TBL] [Abstract][Full Text] [Related]
19. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral metabolism changes in epileptic children receiving valproic acid.
Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
